Experience with regulatory agencies in U S , Europe, Japan, and China. Studies involving 10,000 sites in 70 countries.
Tell Us About Your Trial
Our Locations
U.S. (Massachusetts)
WorldCare Clinical
135 Beaver St
Suite 208
Waltham MA, 02452
U.S. (Pleasanton)
WorldCare Clinical
5976 W. Las Positas Blvd
Suite 120
Pleasanton, CA 94588
United Kingdom
WorldCare Clinical
Peter House
Oxford Street
Manchester
M1 5AN
United Kingdom
India
WorldCare Clinical
Mount Banjara Complex
8-2-630/B/B/1, Rd Number 12
Banjara Hills, Hyderabad, Telangana 500034
India
U.S. (New York)
DARC
111 Great Neck Rd., Suite 300
Great Neck, NY 11021 USA
(212) 935-3039
Jeff Schneebaum
Director of Operations, Ophthalmology
Jeff oversees the operations of the ophthalmic team at WorldCare Clinical. Jeff has served as Director of Operations at Digital Angiography Reading Center (DARC) for more than 13 years, helping to build the first all-digital ophthalmic reading center for clinical trials. Jeff has more than 20 years of experience working at Fortune 100 companies such as Credit Suisse First Boston and Colgate Palmolive. Jeff joined WCC in 2021 with the combination of DARC and WCC.
Jason Slakter, M.D.
Medical Director
Dr. Slakter is an internationally recognized retinal disease specialist with over 30 years of experience in clinical practice. He created the Digital Angiography Reading Center (DARC), which is one of the largest centers for image evaluation for clinical trials of posterior segment disease with over 1,600 certified clinical sites in over 70 countries worldwide, serving as a key resource for industry-sponsored studies of new treatments for retinal disorders. Dr. Slakter is also a Clinical Professor of Ophthalmology at NYU School of Medicine and has published more than 100 papers and book chapters. Dr. Slakter serves as the Chief Executive Officer of Orphion Therapeutics, Inc., a gene therapy company focused on developing new treatments to meet unmet needs for rare genetic diseases. Dr. Slakter is WCC’s Medical Director for Ophthalmology and has worked with WCC since the combination of DARC and WCC in 2021.
Matt Heggem
Vice President, Program Management
Matt Heggem oversees the progress and performance of key programs at WCC. He has over 17 years of experience supporting clinical trial programs in the imaging space across various therapeutic areas including Musculoskeletal, Immunology, Neurology, Cardiology, Orthopedics and Oncology. Before joining WCC, Matt held various leadership roles at Synarc and BioClinica, including most recent positions of Managing Director of Global Services and Director of Program & Project Management. To compliment his extensive program management experience, Matt has an MBA with a specialization in Project Management and holds PMP and PgMP certifications from the Project Management Institute.
Richard Walovitch, Ph. D.
Chief Scientific Officer
Dr. Walovitch is Chief Scientific Officer of WCC, which he joined as Chief Medical Officer in January 2009. Prior to joining WCC, he served as the Senior Vice President of clinical research at Acusphere, Inc., Vice President of Preclinical and Clinical Research at Epix Medical, and held various positions as Research Pharmacologist and Project Clinician in the Imaging Agent Group at the DuPont Merck Pharmaceutical Company. He completed his postdoctoral fellowship at the National Institute on Drug Abuse’s Addiction Research Center in the Neurochemistry section. Dr. Walovitch has a Doctorate in Pharmacology from the University of Illinois Medical Center and a Bachelor’s degree in biology from the University of Illinois. He is an author of more than 100 peer-reviewed publications, mostly in the field of medical imaging.
Aaron Timm
Chief Executive Officer
Aaron Timm is CEO of WorldCare Clinical. Aaron joined WCC as CEO in November 2014 and has led the company’s successful growth and global expansion. Prior to joining WCC, he served as Chief Executive Officer of Synarc, an imaging CRO, from 2010 to 2014. Aaron joined Synarc as General Counsel in 2005. Earlier in his career, he worked as General Counsel of Vitria Technology, a publicly-traded software company. Aaron began his career practicing corporate law with Orrick, Herrington, & Sutcliffe LLP in San Francisco. He graduated summa cum laude from Georgetown University and with honors from Harvard Law School.